伊布替尼
威尼斯人
医学
慢性淋巴细胞白血病
内科学
肿瘤科
微小残留病
危险系数
美罗华
白血病
淋巴瘤
置信区间
作者
Talha Munir,David A. Cairns,Adrian Bloor,David Allsup,Kate Cwynarski,Andrew R. Pettitt,Shankara Paneesha,Christopher P. Fox,Toby A. Eyre,Francesco Forconi,Nagah Elmusharaf,Ben Kennedy,John G. Gribben,Nicholas Pemberton,Oonagh Sheehy,Gavin Preston,Anna Schuh,Renata Walewska,Lelia Duley,Dena Howard
标识
DOI：10.1056/nejmoa2310063
摘要
MRD-directed ibrutinib-venetoclax improved progression-free survival as compared with FCR, and results for overall survival also favored ibrutinib-venetoclax. (Funded by Cancer Research UK and others; FLAIR ISRCTN Registry number, ISRCTN01844152; EudraCT number, 2013-001944-76.).
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
Criminology34
脑袋困掉了
GingerF
11111
学术文献互助
喜悦的雁山
zp560
YifanWang
caibaozi
大力的灵雁
鸟兽兽
无极微光
MchemG
Freya1528
yue
火星上的天亦
OsamaKareem
smile
xiaolizi
贪玩的秋柔
皖公网安备34019202002308
